Simplex Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,758
| Closed | -$21.5K | – | 9690 |
|
|
2025
Q4 | $17K | Sell |
14,758
-58,529
| -80% | -$80.4K | ﹤0.01% | 6625 |
|
|
2025
Q3 | $98K | Buy |
73,287
+20,607
| +39% | +$23.4K | ﹤0.01% | 5767 |
|
|
2025
Q2 | $49K | Sell |
52,680
-122,302
| -70% | -$79.2K | ﹤0.01% | 5936 |
|
|
2025
Q1 | $80K | Buy |
174,982
+78,899
| +82% | +$49.8K | ﹤0.01% | 5298 |
|
|
2024
Q4 | $71K | Buy |
+96,083
| New | +$116K | ﹤0.01% | 5505 |
|
|
2024
Q3 | – | Sell |
-84,637
| Closed | -$151K | – | 9107 |
|
|
2024
Q2 | $142K | Buy |
+84,637
| New | +$152K | ﹤0.01% | 4993 |
|
|
2024
Q1 | – | Sell |
-54,248
| Closed | -$117K | – | 9415 |
|
|
2023
Q4 | $82K | Buy |
+54,248
| New | +$64.5K | ﹤0.01% | 5587 |
|
|
2023
Q3 | – | Sell |
-20,926
| Closed | -$36.7K | – | 9328 |
|
|
2023
Q2 | $47K | Sell |
20,926
-24,698
| -54% | -$65.6K | ﹤0.01% | 5914 |
|
|
2023
Q1 | $110K | Buy |
45,624
+28,416
| +165% | +$65.1K | ﹤0.01% | 5048 |
|
|
2022
Q4 | $32K | Buy |
17,208
+2,373
| +16% | +$5.05K | ﹤0.01% | 6382 |
|
|
2022
Q3 | $35K | Buy |
14,835
+10,766
| +265% | +$29.8K | ﹤0.01% | 6890 |
|
|
2022
Q2 | $7K | Sell |
4,069
-6,109
| -60% | -$11.7K | ﹤0.01% | 8598 |
|
|
2022
Q1 | $21K | Sell |
10,178
-36,967
| -78% | -$102K | ﹤0.01% | 8206 |
|
|
2021
Q4 | $185K | Sell |
47,145
-12,129
| -20% | -$58.9K | ﹤0.01% | 5313 |
|
|
2021
Q3 | $258K | Sell |
59,274
-11,139
| -16% | -$45.7K | ﹤0.01% | 5168 |
|
|
2021
Q2 | $323K | Buy |
70,413
+44,739
| +174% | +$215K | ﹤0.01% | 4855 |
|
|
2021
Q1 | $0 | Sell |
25,674
-130,808
| -84% | -$906K | ﹤0.01% | 9483 |
|
|
2020
Q4 | $535K | Buy |
+156,482
| New | +$298K | ﹤0.01% | 3338 |
|
|
2020
Q3 | – | Sell |
-7,419
| Closed | -$13.2K | – | 8165 |
|
|
2020
Q2 | $14K | Sell |
7,419
-6,766
| -48% | -$13.3K | ﹤0.01% | 6449 |
|
|
2020
Q1 | $27K | Buy |
14,185
+6,794
| +92% | +$20.2K | ﹤0.01% | 5709 |
|
|
2019
Q4 | $30K | Buy |
+7,391
| New | +$28.5K | ﹤0.01% | 5655 |
|
|
2019
Q1 | – | Sell |
-58,586
| Closed | -$356K | – | 7517 |
|
|
2018
Q4 | $389K | Buy |
58,586
+45,657
| +353% | +$370K | ﹤0.01% | 2458 |
|
|
2018
Q3 | $137K | Buy |
12,929
+12,820
| +11,761% | +$147K | ﹤0.01% | 4085 |
|
|
2018
Q2 | $1K | Sell |
109
-25
| -19% | -$256 | ﹤0.01% | 7167 |
|
|
2018
Q1 | $1K | Sell |
134
-458
| -77% | -$4.24K | ﹤0.01% | 5679 |
|
|
2017
Q4 | $5K | Sell |
592
-42,024
| -99% | -$437K | ﹤0.01% | 4516 |
|
|
2017
Q3 | $523K | Buy |
+42,616
| New | +$629K | 0.02% | 645 |
|
|
2017
Q2 | – | Sell |
-34,131
| Closed | -$529K | – | 6489 |
|
|
2017
Q1 | $489K | Buy |
34,131
+27,104
| +386% | +$402K | 0.02% | 681 |
|
|
2016
Q4 | $97K | Buy |
+7,027
| New | +$113K | 0.01% | 1558 |
|
|
2016
Q3 | – | Sell |
-16,380
| Closed | -$264K | – | 6168 |
|
|
2016
Q2 | $235K | Buy |
16,380
+16,257
| +13,217% | +$220K | 0.02% | 904 |
|
|
2016
Q1 | $1K | Sell |
123
-1,678
| -93% | -$17.6K | ﹤0.01% | 5153 |
|
|
2015
Q4 | $23K | Sell |
1,801
-31,622
| -95% | -$389K | ﹤0.01% | 2566 |
|
|
2015
Q3 | $358K | Buy |
+33,423
| New | +$365K | 0.03% | 579 |
|
Other funds holding LXRX
AG
SL
SC
VCM
Simplex Trading's LXRX Position: Q1 2026 in Review
Simplex Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 14,758 shares — an estimated $21.5K sold.
Simplex Trading first reported a position in LXRX in Q3 2015 and held it in 33 quarters. The position peaked at $535K in Q4 2020. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.
- Simplex Trading reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 14,758 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $21.5K.
- Simplex Trading first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 33 quarters.
- Simplex Trading's Lexicon Pharmaceuticals position peaked at $535K in Q4 2020.
- 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.